Crossmark

Alemtuzumab y síndrome poliglandular autoinmune con diabetes mellitus tipo 1

Crossref DOI link: https://doi.org/10.1016/j.nrl.2023.07.001

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García Estévez, D.A.

Pinal Osorio, I.

Pato Pato, A.
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2024-01-10
More Information

This article is maintained by: Elsevier

Article Title: Alemtuzumab y síndrome poliglandular autoinmune con diabetes mellitus tipo 1

Journal Title: Neurología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrl.2023.07.001

Content Type: simple-article

Copyright: © 2024 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.